It is intriguing to suggest that perhaps this small population of ACE2-expressing cells may underlie the pathogenesis of severe ARDS, pneumonia, and respiratory failure in COVID-19 patients and, perhaps, particularly in those with LUAD. Here, ACE2 is linked to respiratory failure.